unknown
Stage
1
Investors
About
intoDNA develops the STRIDE® platform, which provides high-sensitivity, AI-driven assays for detecting and analyzing DNA damage and repair at the single-cell level to support pharmaceutical research and precision medicine.
Explore intoDNA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.